Atrial Fibrillation — UKMLA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — A licensed-dose DOAC with risk-factor review
The best answer is “A licensed-dose DOAC with risk-factor review”. A DOAC is usually offered for eligible non-valvular AF, using the product-specific dose criteria rather than age alone. Bleeding-risk assessment identifies modifiable hazards and follow-up needs but is not used by itself to deny stroke prevention; aspirin is ineffective for this purpose and a supratherapeutic warfarin target is harmful.
Reference: NICE NG196: Atrial fibrillation diagnosis and management: https://www.nice.org.uk/guidance/ng196/chapter/Recommendations